175552
Reforming the Long-Term Care System: The Cases of England and the Netherlands
Tuesday, October 28, 2008: 1:30 PM
Dennis Kodner, PhD
,
NYIT Center for Gerontology & Geriatrics, New York College of Osteopathic Medicine of New York Institute of Technology (NYIT), Old Westbury, NY
Long-term care (LTC) reform is happening around the world, especially in developed countries. Reform initiatives are being driven by several factors: lack of coordination, inefficient service arrangements, less than optimum quality, poor outcomes, and/or difficult-to-control costs. England and the Netherlands not only represent two different LTC models, but also differing approaches to LTC reform. In addition to examining the respective policy frameworks and financing/service delivery infrastructures that have traditionally defined the LTC systems of England and the Netherlands, the paper describes the drivers of LTC change that have emerged in each country. Next, it summarizes the reforms that have been proposed or implemented to re-finance, re-balance, and/or re-organize LTC in each of the countries and the outcomes found to date, if any. Finally, this review concludes with a discussion of the implications and lessons of these international LTC reform efforts for the U.S.
Learning Objectives: 1. Understand the policy framework and financing/service delivery infrastructure that has traditionally defined the LTC systems of England and the Netherlands.
2. Understand the key driving forces for LTC change in England and the Netherlands.
3. Identify the LTC reform initiatives that have been proposed, or implemented in England and the Netherlands.
4. Evaluate the outcomes, if any, of these respective LTC reform initiatives.
5. Discuss the lessons and implications of these LTC reform initiatives for the U.S.
Keywords: Aging, Long-Term Care
Presenting author's disclosure statement:Qualified on the content I am responsible for because: researcher in the field of comparative LTC systems
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|